In VitroAntibacterial Activity of S-4661, a New Parenteral Carbapenem, against Urological Pathogens Isolated from Patients with Complicated Urinary Tract Infections
- 1 January 2002
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 14 (2) , 155-160
- https://doi.org/10.1179/joc.2002.14.2.155
Abstract
The antibacterial activity of S-4661, a new parenteral carbapenem antibiotic, was assessed against the major urological pathogens isolated from patients with complicated urinary tract infections. S-4661 was slightly less active than imipenem and panipenem, but more active than meropenem and ceftazidime against Gram-positive bacteria. Against Gram-negative bacteria, S-4661 was similar to meropenem, similar to or more effective than imipenem, and more active than panipenem and ceftazidime. Thus S-4661 possesses potent and well-balanced wide-spectrum antibacterial activity against various urological pathogens.Keywords
This publication has 4 references indexed in Scilit:
- In vitro and in vivo antibacterial activities of a new injectable carbapenem, S-4661, against gynaecological pathogens.Journal of Antimicrobial Chemotherapy, 2000
- Comparative in vitro Activity of S-4661, a New Parenteral Carbapenem, and Other Antimicrobial Agents against Respiratory PathogensChemotherapy, 2000
- In Vitro and In Vivo Antibacterial Activities of S-4661, a New CarbapenemAntimicrobial Agents and Chemotherapy, 1998
- In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1993